Radiopharmaceutical Injection Equipment

Description

NHS Greater Glasgow & Clyde require a Shielded Radiopharmaceutical Injector to administer therapeutic radiopharmaceuticals for patients undergoing molecular radiation therapy as part of their cancer treatment, with 156,485.00 GBP charitable money allocated to this purchase. Furthermore, an allocation of 91,607.23 GBP has been assigned for the maintenance of this unit, which includes 2 years’ worth of warranty and 6 years of maintenance support including Servicing, Breakdown labour and parts, and Remote support.
Market engagement suggests no alternative solution for this requirement, due to the below:-
The system must be approved (CE/UKCA) for use with both Lu-177 and I-131 pharmaceuticals, which are the two therapeutic radionuclides the department expect to use the injector for.
It should be possible to swap out vials to allow multi-vial administrations.
Through market engagement the equipment is considered the solitary option for the Health Boards requirement.
In order to award this contract compliantly, NHSGGC will follow Regulation 32 of the Public Contracts (Scotland) Regulations: (2) (b) (ii)
where the works, supplies or services can be supplied only by a particular economic operator for any of the following reasons
(ii)competition is absent for technical reasons